Orthopediatrics (KIDS) Cash & Current Investments (2015 - 2026)

Orthopediatrics' Cash & Current Investments history runs 12 years deep, the most recent figure standing at $48.8 million for Q1 2026.

• In Q1 2026, Cash & Current Investments rose 37.77% year-over-year to $48.8 million; the TTM figure through Mar 2026 stood at $48.8 million (up 37.77% YoY), while the FY2025 annual figure was $21.6 million, down 52.77% from the prior year.
• Cash & Current Investments was $48.8 million for Q1 2026 at Orthopediatrics, up from $21.6 million in the prior quarter.
• In the past five years, Cash & Current Investments ranged from a high of $118.3 million in Q4 2022 to a low of $1.4 million in Q3 2022.
• Historically, Cash & Current Investments has averaged $43.4 million across 5 years, with a median of $38.6 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Cash & Current Investments slumped 97.49% in 2022, then jumped 744.17% in 2023.
• A 5-year view of Cash & Current Investments shows it stood at $118.3 million in 2022, then slumped by 32.11% to $80.3 million in 2023, then sank by 43.0% to $45.8 million in 2024, then plunged by 52.77% to $21.6 million in 2025, then soared by 125.76% to $48.8 million in 2026.
• The last three Cash & Current Investments figures came in at $48.8 million (Q1 2026), $21.6 million (Q4 2025), and $18.9 million (Q3 2025), per Business Quant data.